Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,027,318 papers from all fields of science
Search
Sign In
Create Free Account
Sch 39166
Known as:
Sch-39166
, Sch39166
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Ecopipam Hydrochloride
Broader (1)
ecopipam
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Role of Dorsomedial Striatum Neuronal Ensembles in Incubation of Methamphetamine Craving after Voluntary Abstinence
D. Caprioli
,
M. Venniro
,
+4 authors
Y. Shaham
Journal of Neuroscience
2017
Corpus ID: 40432359
We recently developed a rat model of incubation of methamphetamine craving after choice-based voluntary abstinence. Here, we…
Expand
Review
2013
Review
2013
Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
Na Ye
,
J. Neumeyer
,
R. Baldessarini
,
Xuechu Zhen
,
A. Zhang
Chemical Reviews
2013
Corpus ID: 6632099
Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders Na Ye,† John L. Neumeyer,‡ Ross J…
Expand
Highly Cited
2008
Highly Cited
2008
Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior
K. Sink
,
V. K. Vemuri
,
T. Olszewska
,
A. Makriyannis
,
J. Salamone
Psychopharmacology
2008
Corpus ID: 19816061
RationaleCannabinoid CB1 antagonists/inverse agonists suppress food-motivated behaviors and are being evaluated as potential…
Expand
Highly Cited
2004
Highly Cited
2004
Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats
A. Barrett
,
John Miller
,
Jennifer M. Dohrmann
,
S. Caine
Neuropharmacology
2004
Corpus ID: 2959198
Highly Cited
2001
Highly Cited
2001
Enduring Resistance to Extinction of Cocaine-Seeking Behavior Induced by Drug-Related Cues
F. Weiss
,
R. Martin‐Fardon
,
R. Ciccocioppo
,
T. Kerr
,
Diana L. Smith
,
O. Ben-shahar
Neuropsychopharmacology
2001
Corpus ID: 16056559
Highly Cited
1999
Highly Cited
1999
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)
M. Romach
,
Paul Glue
,
+8 authors
Edward M. Sellers
Archives of General Psychiatry
1999
Corpus ID: 35158428
BACKGROUND The subjective and reinforcing effects of cocaine in humans are associated with the enhancement of endogenous dopamine…
Expand
Highly Cited
1996
Highly Cited
1996
Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex
B. Ellenbroek
,
S. Budde
,
A. Cools
Neuroscience
1996
Corpus ID: 24865136
Highly Cited
1995
Highly Cited
1995
Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease
L. Burns
,
P. Pakzaban
,
+4 authors
O. Isacson
Neuroscience
1995
Corpus ID: 35785605
Highly Cited
1994
Highly Cited
1994
Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors.
Jialing Liu
,
J. Nickolenko
,
F. Sharp
Proceedings of the National Academy of Sciences…
1994
Corpus ID: 24408914
Morphine induced the c-fos and junB immediate early genes in neurons of the medial and ventral striatum and nucleus accumbens…
Expand
Highly Cited
1988
Highly Cited
1988
Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
R. Chipkin
,
L. Iorio
,
V. Coffin
,
R. Mcquade
,
J. Berger
,
A. Barnett
Journal of Pharmacology and Experimental…
1988
Corpus ID: 38104042
SCH39166 [(-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl- 5H-benzo[d]naptho-(2,1-b)azepine] is a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE